Every dispense, every claim, every purchase, every rebate reconciled into working queues that pharmacy, finance, or procurement can manage.
ILLUSTRATIVE · SAMPLE DATA
A patient sees their provider. A prescription is written and filled. An administrator confirms it qualifies. The drug is replenished at the discounted price. The benefit is realized. For most of the program's life, that was the whole of it. Until it wasn't.
A prescriber who was never enrolled generates no alert. A refill that moves out of network generates no exception. A claim that qualified correctly and was then purchased at full price passes every check you have.
These are not problems waiting in a queue. They are absences — and you cannot sample your way to something that left no record. It has to be every one, every time, the same way. Only a record assembled from every source can do that — and the difference between it and what actually happened is the queue.
Every one that happened. Not only the ones that were claimed.
What qualified, what didn't, and exactly which rule decided.
Matched to the dispense it replenished, at the price in effect.
Filed inside the window, checked against what it should have paid.
Five queues, owned and cleared. This is revenue cycle management, applied to a program that never had the record to support it.
Medical billing has a charge master — a record of every service that should generate a claim. 340B has never had one. Proximity builds it, organized around the patient and assembled independently of what was submitted, so you can see which interactions should have produced claims at all.
A claim can pass every check — administrator, submission platform, wholesaler — and still be replenished at full price. Nothing generates an alert, because no system compares your qualified claims against your wholesaler invoices. We do, at the level of the individual product, pharmacy and date.
Until now, a missed 340B dollar stayed missable — you could find it in March and still recover it. The rebate model ends that on January 1, 2027: a qualifying dispense has a window, and when it closes the money is gone, not deferred. For Maximum Fair Price you file nothing at all, and only the purchase record can tell an MFP claim from a 340B one.
ILLUSTRATIVE · SAMPLE DATA
You are accountable in an audit. Not your vendor. Every conclusion is deterministic — same inputs, same finding, from stated rules rather than inference — and each traces back to the rule, the reference data, and the records it ran against. Models help author rules. They do not produce conclusions.
You are not asked to export files, reconcile formats, or upload anything. We submit what you direct, to destinations you name. We do not sell, license, or share your dispense-level data with manufacturers, pharmacy benefit managers, or their agents — there is no second customer for it.
Your program is the financial foundation of your mission. Start with the gap we can quantify from public data, before you give us access to anything: registered sites operating without their own contract pharmacies.
In-house dispensing, mixed use, and contract pharmacy are almost never measured together. Start with the check almost nobody has run: your wholesaler invoices against your qualified claims.
Manufacturers have spent two decades measuring what 340B costs them. Covered entities have no equivalent for measuring what it produces. Six pages on why, and what closing the gap requires.
It stays empty until then. A testimonial that says "great partner to work with" would be worse than nothing here.
That instrument has never existed.
We build it.
Proximity works on 340B and nothing else. One program, at a depth that is only possible if it is the only thing you build for.